Back to Authors

Arab, Juan Pablo

https://orcid.org/0000-0002-8561-396X

A5049575058 | I184840846

Mayo Clinic

Virginia Commonwealth University

Citations 50

Hepatology Highlights

Hepatology | November 14, 2022 | Volume: 76 | Issue: 6 | Pages: 1555-1556

10.1002/hep.32795

Hepatology highlights

Hepatology | October 19, 2022 | Volume: 76 | Issue: 5 | Pages: 1231-1232

10.1002/hep.32747

Hepatology highlights

Hepatology | September 19, 2022 | Volume: 76 | Issue: 4 | Pages: 901-902

10.1002/hep.32683

Hepatology highlights

Hepatology | August 9, 2022 | Volume: 76 | Issue: 3 | Pages: 539-540

10.1002/hep.32625

Hepatology Highlights

Hepatology | July 16, 2022 | Volume: 76 | Issue: 2 | Pages: 287-288

10.1002/hep.32593

Hepatology Highlights

Hepatology | June 18, 2022 | Volume: 76 | Issue: 1 | Pages: 1-2

10.1002/hep.32567

Hepatology highlights

Hepatology | May 17, 2022 | Volume: 75 | Issue: 6 | Pages: 1363-1364

10.1002/hep.32524

Identifying Alcohol Use Disorder in Patients With Cirrhosis Reduces 30-Days Readmission Rate

Alcohol and Alcoholism | May 5, 2022 | Volume: 57 | Issue: 5 | Pages: 576-580

10.1093/alcalc/agac015 | PMID 35544033

Abstract Aims Readmission is frequent among patients with cirrhosis and is a complex multifactorial process. To examine the association of alcohol use disorder (AUD) and risk of readmission in patients with alcohol-associated cirrhosis. Methods and Results National Readmission Dataset (2016–2017) was used to extract a retrospective cohort of 53,348 patients with primary or secondary discharge diagnosis code of alcohol-associated cirrhosis with their first admission (26,674 patients with vs. propensity matched 26,674 without a primary or secondary discharge diagnosis code of AUD). Readmission within 30-day was lower (43.9 vs. 48%, P < 0.001) among patients identified to have AUD at the time of discharge. In a conditional logistic regression model, a diagnosis of AUD was associated with 15% reduced odds of 30-day readmission, 0.85 (0.83–0.88). Furthermore, the reason for readmission among patients identified vs. not identified to have AUD was less likely to be liver disease complication. The findings remained similar in a matched cohort of patients where the AUD diagnosis at discharge was listed as one of the secondary diagnoses only. Conclusion Although, our study findings suggest that identification of AUD at the time of discharge among patients hospitalized for alcohol-associated cirrhosis reduces the risk of 30-day readmission, unavailable information on patient counseling, referral for mental health specialist and treatment received for AUD limit the causality assessment. Future studies are needed overcoming the inherent limitations of the database to establish the role of identification and treatment of AUD in reducing readmission and liver decompensation in patients with alcohol-associated cirrhosis.
Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

American Journal of Gastroenterology | May 3, 2022 | Volume: 117 | Issue: 5 | Pages: 818-818

10.14309/ajg.0000000000001704 | PMID 35501978

Hepatology highlights

Hepatology | April 22, 2022 | Volume: 75 | Issue: 5 | Pages: 1071-1072

10.1002/hep.32488